Results 21 to 30 of about 447,839 (304)

Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center

open access: yesFrontiers in Endocrinology, 2021
IntroductionMedullary thyroid carcinoma (MTC) is a rare cancer that accounts for 5% of thyroid cancers. Serum calcitonin is a good biomarker for MTC, which is used for diagnosis, prognosis, and monitoring of recurrence. Calcitonin-negative MTC (CNMTC) is
Sun Jung Kim   +4 more
doaj   +1 more source

Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells [PDF]

open access: yes, 2016
n this study we analyzed the expression levels of markers of epithelial-to-mesenchymal transition (EMT) in several papillary thyroid carcinomas (PTCs) and the relation with tumor genotypes and clinicopathological characteristics.
Bulotta, Stefania   +11 more
core   +1 more source

Predictors of distant metastasis in parotid acinic cell carcinoma

open access: yesBMC Cancer, 2019
Background Distant metastasis (DM) is a common treatment failure pattern in acinic cell carcinoma (AciCC) of the major salivary glands; therefore, the main goal of this study was to analyse the predictors of DM in parotid AciCC.
Qigen Fang, Junfu Wu, Wei Du, Xu Zhang
doaj   +1 more source

Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children? [PDF]

open access: yes, 2013
Surgical diseases of the thyroid in the pediatric population represent a diverse set of both benign and malignant conditions. Overall, incidence is rare.
Breuer, Christopher   +3 more
core   +1 more source

Goiter frequency is more strongly associated with gastric adenocarcinoma than urine iodine level [PDF]

open access: yes, 2013
Purpose: We designed our study to evaluate the hypothesis that gastric cancer is correlated with iodine deficiency or thyroid dysfunction. Materials and Methods: We investigated the total body iodine reserve, thyroid function status and autoimmune ...
Adabi, K.   +12 more
core   +1 more source

Thyroid cancer

open access: yesMedical Clinics of North America, 1993
Management of thyroid cancer varies somewhat between communities and institutions depending on tumor type and individual treatment philosophy. The differentiated thyroid cancers have a significantly better outlook than the medullary and anaplastic. This article provides an overview of the literature that describes pathogenesis, diagnosis, and treatment
R B, Sessions, B J, Davidson
openaire   +2 more sources

Tissue culture of human thyroid cancer [PDF]

open access: yes, 1968
Human thyroid cancer cells in the pleural effusion were serially cultivated in vitro. Three kinds of cell lines were established from the same primary culture and were designated as PS, TS and TR lines, respectively.
Hirose, Masaharu
core   +1 more source

DNA double-strand break repair gene mutation and the risk of papillary thyroid microcarcinoma: a case–control study

open access: yesCancer Cell International, 2021
Objective To study the relationship between DNA double-strand break (DSB) repair gene mutations and the risk of papillary thyroid microcarcinoma (PTMC). Methods One hundred patients with PTMC or benign thyroid nodules (BTNs) at Henan Cancer Hospital were
Jiali Qin   +5 more
doaj   +1 more source

Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer [PDF]

open access: yes, 2016
Context: The European Thyroid Association (ETA) has classified post-treatment cervical ultrasound findings in thyroid cancer patients based on their association with disease persistence/recurrence.
BIFFONI, Marco   +12 more
core   +1 more source

Zn(II)-curc targets p53 in thyroid cancer cells [PDF]

open access: yes, 2015
P53 mutation is a common event in many cancers, including thyroid carcinoma. Defective p53 activity promotes cancer resistance to therapies and a more malignant phenotype, acquiring oncogenic functions.
Crispini, Alessandra   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy